These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Current developments in gene therapy for epidermolysis bullosa. Kocher T; Petkovic I; Bischof J; Koller U Expert Opin Biol Ther; 2022 Sep; 22(9):1137-1150. PubMed ID: 35235467 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous mosaicism: right before our eyes. Frank J; Happle R J Clin Invest; 2007 May; 117(5):1216-9. PubMed ID: 17476352 [TBL] [Abstract][Full Text] [Related]
38. Epidermolysis bullosa care in Austria and the Epidermolysis Bullosa House Austria. Pohla-Gubo G; Hintner H Dermatol Clin; 2010 Apr; 28(2):415-20, xv. PubMed ID: 20447517 [TBL] [Abstract][Full Text] [Related]
39. One goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disorders. Hünefeld C; Mezger M; Kern JS; Nyström A; Bruckner-Tuderman L; Müller I; Handgretinger R; Röcken M Exp Dermatol; 2013 Mar; 22(3):162-7. PubMed ID: 23489418 [TBL] [Abstract][Full Text] [Related]
40. Translational perspectives to treat Epidermolysis bullosa-Where do we stand? Prodinger C; Bauer JW; Laimer M Exp Dermatol; 2020 Nov; 29(11):1112-1122. PubMed ID: 33043517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]